
TECHNOLOGIES

HPC
Hydrophilic Polymer CoatingHPC is an aneurysm implant and Flow Diverter coating, which shall reduce the risk of thrombosis on the surface of stents. Due to the thrombogenic surface, platelet function-inhibiting drugs are needed to prevent in-stent thrombosis. The current solution of preventing platelet activation is the Dual Anti-Platelet Therapy (DAPT) consisting of Aspirin and Clopidogrel. HPC reduces the risk of thrombus formation on the implant by initially reducing or preventing the adhesion of platelets when in contact with blood. The whole implant is covered with an invisible coating.
For more information click here.
NEWS
Results of the international Diversion-p64 study: The largest real-world Flow Diverter experience – Recording is available!
30. November 2020
The ESMINT webinar provides the opportunity to meet experts, who share their experience, practice, and way of thinking regarding everyday challenges in the field of neurointerventions. Share this Post Results of the international Diversion-p64 study: the largest real-world Flow Diverter experience - Recording is available! On Monday, 30 November 2020,...
Read More
UPCOMING EVENTS
February
March
April
May
September